BCG and New Preventive Tuberculosis Vaccines: Implications for Healthcare Workers

Clin Infect Dis. 2016 May 15;62 Suppl 3(Suppl 3):S262-7. doi: 10.1093/cid/ciw025.

Abstract

Healthcare workers (HCWs) are at high risk of Mycobacterium tuberculosis (Mtb) infection and tuberculosis disease, but also play a crucial role in implementing healthcare. Preexposure tuberculosis vaccination, including revaccination with BCG, might benefit Mtb-uninfected HCWs, but most HCWs in tuberculosis-endemic countries are already sensitized to mycobacteria. A new postexposure tuberculosis vaccine offers greatest potential for protection, in the setting of repeated occupational Mtb exposure. Novel strategies for induction of mycobacteria-specific resident memory T cells in the lung by aerosol administration, or induction of T cells with inherent propensity for residing in mucosal sites, such as CD1-restricted T cells and mucosa-associated innate T cells, should be explored. The need for improved protection of HCWs against tuberculosis disease is clear. However, health systems in tuberculosis-endemic countries would need significantly improved occupational health structures to implement a screening and vaccination strategy for HCWs.

Keywords: healthcare workers; prevention; tuberculosis; vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • BCG Vaccine*
  • Health Personnel*
  • Humans
  • Occupational Diseases* / immunology
  • Occupational Diseases* / prevention & control
  • Occupational Exposure
  • South Africa
  • Tuberculosis Vaccines*
  • Tuberculosis* / immunology
  • Tuberculosis* / prevention & control

Substances

  • BCG Vaccine
  • Tuberculosis Vaccines